0.000
0.00 (0.00%)
| Previous Close | 0.000 |
| Open | 0.000 |
| Volume | 26,254 |
| Avg. Volume (3M) | 1,713 |
| Market Cap | 1,400 |
| 52 Weeks Range | |
| Earnings Date | 17 Jan 2025 - 28 Jan 2025 |
| Profit Margin | -83.20% |
| Operating Margin (TTM) | -124.83% |
| Diluted EPS (TTM) | -6.39 |
| Quarterly Revenue Growth (YOY) | -48.80% |
| Total Debt/Equity (MRQ) | 49.25% |
| Current Ratio (MRQ) | 1.21 |
| Operating Cash Flow (TTM) | -2.90 M |
| Levered Free Cash Flow (TTM) | -5.75 M |
| Return on Assets (TTM) | -13.01% |
| Return on Equity (TTM) | -103.78% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Pharmaceutical Retailers (US) | Mixed | Mixed |
| Pharmaceutical Retailers (Global) | Mixed | Bearish | |
| Stock | BIMI International Medical Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | 0.13 |
|
BIMI Holdings Inc is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. It operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and OTC medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. Medical services include private comprehensive hospitals operating in China. |
|
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Investment Style | Small Value |
| % Held by Insiders | 93.51% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |